Movement Alert|ImmunityBio, Inc. Falls 4.26% in Regular Trading, Q3 miss and wider loss continue to weigh on shares

Market Focus
Nov 20

On November 20, ImmunityBio, Inc. fell 4.26% in Regular Trading, trading at $6.29 per share, with turnover of $13.1524 million.

The move aligned with continued market digestion of the company’s recent third-quarter results, which missed expectations on both revenue and adjusted earnings while net loss widened, continuing to pressure sentiment.

Third-quarter revenue was $48.841 million, below the $59.250 million consensus estimate. Adjusted EPS was a loss of $0.09 versus an expected loss of $0.08, while net loss widened to $0.18 per diluted share from $0.07 a year earlier. Although recent updates on Anktiva included Israeli regulatory approval, first patient treatment in Europe, and a bladder cancer registrational trial meeting its primary endpoint, those developments have not fully offset investor concern over financial performance and commercialization execution.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10